Gerontology/Geriatrics Topic Homepage

Medical Videos

Ask The Geriatrician - The Physiology of Ageing
Ask The Geriatrician - The Physiology of Ageing

Recent Drug Updates

Clinical Guidelines

Falls: assessment and prevention of falls in older people

Jun 2013

This clinical guideline extends and replaces NICE clinical guideline 21 (published November 2004)...

... It offers evidence-based advice on preventing falls in older people. New recommendations have been added about preventing falls in older people during a hospital stay. All people aged 65 or older are covered by all guideline recommendations. People aged 50 to 64 who are admitted to hospital and are judged by a clinician to be at higher risk of falling because of an underlying condition are also covered by the guideline recommendations about assessing and preventing falls in older people during a hospital stay.

Managing older people with type 2 Diabetes

Jan 2013

This Guideline has been structured into main chapter headings dealing with expected areas such as..

... cardiovascular risk, education, renal impairment, diabetic foot disease and so on, but also includes less commonly addressed areas such as seen such as sexual health. Also included is a section of ‘special considerations’ where areas such as pain and end of life care are addressed.

Online CME

Clinical Review - Urinary incontinence in women

This activity reviews the assessment, classification and management of women presenting with urinary incontinence.

Anticonvulsants for Postherpetic Neuralgia: Evidence-based Recommendations

This activity is intended for neurologists, primary care clinicians, anesthesiologists, and geriatricians. The goal of this activity is to discuss current practice guidelines and the use of anticonvulsants for the...

e-LfH Dementia

Dementia is becoming increasingly prevalent, both due to our ageing population and improved recognition of the condition. However, the nature of dementia means that managing the condition can pose unique...

Clinical Trials

Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma

11-07-2014

The purpose of this trial is to determine

  1. Objective response rate (ORR), defined as the proportion of patients having CR, CRr or PR in the centrally reviewed restaging after six cycles of chemotherapy
  2. Progression-free survival (PFS) 3 years after registration

Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease (MeMO-RV2)

25-06-2014

Cognitive and memory problems characterize Alzheimer's disease (AD). Along with these disorders, psychological and behavioral symptoms (also known as neuropsychiatric symptoms) , as well as pathophysiological processes are frequently found and involved significantly in maintaining autonomy, prognosis and..

... treatment of the disease. Apathy or disorder motivation is the most common disorder behavior and early stages of cognitive impairment. Apathy is particularly associated with cognitive difficulties such as attention deficit disorder - concentration.

In terms of prevention as term care , there is now a broad consensus that interventions on cognition and behavior must not be limited to pharmacological treatment but should also promote non-drug approaches.

Interest in video games (serious games and serious games) as intervention support rehabilitation is growing. Similarly, the virtual reality (VR) and the new information technologies and communications offer significant opportunities in terms of rehabilitation and therapeutic assistance.

This protocol is part of a European project to propose techniques for improving the treatment of people at risk of social exclusion ( VERVE project ) aims .

A first experiment conducted in 2013 showed the acceptability of Virtual Reality (VR) in healthy elderly subjects. In a second step , it is important to validate the feasibility of using the RV or in frail subjects with mild cognitive impairment or Alzheimer's disease in mild to moderate in a clinical environment.

This is a biomedical , randomized given to a group of patients with mild cognitive impairment or Alzheimer's disease & diseases associated with mild to moderate.

Back to top